Rankings
▼
Calendar
APLS FY 2013 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
APLS
Apellis Pharmaceuticals, Inc.
$2B
FY 2013 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.86
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$271,841
Balance Sheet
Total Assets
$5M
Total Liabilities
$676,955
Stockholders' Equity
$5M
Cash & Equivalents
$5M
← FY 2014
All Quarters
